Free Account Opening + AMC Free Demat
Loading...

Ajanta Pharma Buyback vs TCS Buyback

Comparision between Ajanta Pharma Buyback and TCS Buyback.

Buyback Details

Ajanta Pharma Buyback is a Tender Offer buyback proposed to list at BSE, NSE while TCS Buyback is a Tender Offer proposed to list at BSE, NSE.

  Ajanta Pharma Limited Tata Consultancy Services
Logo Ajanta Pharma Buyback Logo TCS Buyback Logo
Type of Buyback Tender Offer Tender Offer
Listing At BSE, NSE BSE, NSE
Face Value ₹2 per share ₹1 per share
Buyback Price ₹2550 per share ₹4500 per share
Issue Size 11,20,000 shares 4,00,00,000 shares
Issue Size (Amount) ₹285.60 Crores ₹18,000.00 Crores
Buyback Ratio
Category Entitlement Ratio of Buyback
Reserved Category for Small Shareholders 30 Equity Shares out of every 151 shares held on the record date.
General Category for all other Eligible Shareholders 1 Equity Shares out of every 91 shares held on the record date.

Buyback Ratio Calculation
Registrar Link Intime India Private Ltd Link Intime India Private Ltd
Lead Managers Vivro Financial Services Private Limited Jm Financial Limited
Necessity of the buyback

The Buyback aims to :
i) Distribute surplus funds to shareholders and thereby enhance their overall return.
ii) Improve financial ratios like Earnings per share (EPS), Return on assets (ROA) and Return on Equity (ROE).

The Buyback aims to :
i) Return excess cash to the shareholders.
ii) Increase shareholder's value in the long term; and
iii) Improve Return on Equity.

Buyback Timetable

Ajanta Pharma Buyback and TCS Buyback buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Ajanta Pharma Buyback Buyback record date is Jan 14, 2022. TCS Buyback Buyback record date is Feb 23, 2022.

  Ajanta Pharma Limited Tata Consultancy Services
Record Date Jan 14, 2022 Feb 23, 2022
Offer Open Date Feb 03, 2022 Mar 09, 2022
Offer Closure Date Feb 16, 2022 Mar 23, 2022
Last date for receipt of tender forms Feb 16, 2022 Mar 23, 2022
Finalisation of buyback Feb 24, 2022 Mar 31, 2022
Last Date for settlment of bids Feb 25, 2022 Apr 01, 2022
Last Date for extinguishment of shares Mar 04, 2022 Apr 08, 2022

Financial Details and Other Relevent Information

Comparison of Ajanta Pharma Buyback and TCS Buyback financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Ajanta Pharma Limited Tata Consultancy Services
Financial
Summary of financial Information Consolidated)
Particulars For the year/period ended (Rs. in Crores)
  30-Sep-21 31-Mar-21 31-Mar-20
Total Income 1,694.96 2,915.67 2,680.06
Profit After Tax 369.69 653.87 467.70
Net Worth 3,358.90 2,995.63 2,598.87
Reserves and Surplus 3,341.51 2,978.24 2,581.33
Summary of financial Information (standalone)
Particulars For the year/period ended (Rs. in Millions)
31-Dec-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Income 1,233,870.00 1,413,630.00 1,393,830.00 1,307,970.00
Profit After Tax 283,920.00 309,600.00 332,600.00 300,650.00
Net Worth 923,929.10 747,939.10 743,682.40 788,982.40
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2021 2239.10 2015.80 2136.74
Oct-2021 2366.30 2053.65 2213.24
Sep-2021 2340.00 2112.70 2199.31

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2022 3857.00 3695.60 3782.93
Jan-2022 4019.10 3650.10 3847.53
Dec-2021 3736.85 3534.35 3630.88
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2021 2239.10 2000.00 2137.44
Oct-2021 2365.80 2053.65 2213.37
Sep-2021 2330.00 2110.00 2201.05

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2022 3856.20 3694.95 3782.74
Jan-2022 4019.15 3649.25 3847.37
Dec-2021 3738.35 3536.40 3631.14

Comments

Add a public comment...